Sam68 expression and cytoplasmic localization is correlated with lymph node metastasis as well as prognosis in patients with early-stage cervical cancer

Annals of Oncology

Volumn 23, Issue 3, 2012, Pages 638-646

  Li, Z ^a,c   Yu, C P ^a   Zhong, Y ^a   Liu, T J ^b   Huang, Q D ^a   Zhao, X H ^a   Huang, H ^a   Tu, H ^a   Jiang, S ^a   Zhang, Y ^a   Liu, J H ^a   Song, L B ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b Laura Biotech Co Ltd   (China)

^c KUNMING MEDICAL UNIVERSITY   (China)

Author keywords

Cervical cancer; EMT; Pelvic lymph node metastasis; Prognosis; Sam68

Indexed keywords

GLYCOGEN SYNTHASE KINASE 3BETA; MESSENGER RNA; PROTEIN KINASE B; PROTEIN SAM68; SHORT HAIRPIN RNA; TRANSCRIPTION FACTOR SNAIL;

ADULT; ARTICLE; CANCER CELL; CANCER INVASION; CANCER STAGING; CANCER SURVIVAL; CELL MOTILITY; CONTROLLED STUDY; CYTOPLASM; DISEASE FREE SURVIVAL; DOWN REGULATION; ENZYME INHIBITION; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PELVIS LYMPH NODE; POLYMERASE CHAIN REACTION; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; RISK ASSESSMENT; RISK FACTOR; RNA INTERFERENCE; SURVIVAL TIME; TISSUE SECTION; UPREGULATION; UTERINE CERVIX CANCER; WESTERN BLOTTING;

EID: 84863230459     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdr290     Document Type: Article

References (32)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74-108.
2. Berek JS. Hacker, NF. Practical Gynecologic Oncology. Philadelphia, PA: Lippincott Williams & Wilkins 2004.
3. Lukong KE, Richard S. Sam68, the KH domain-containing superSTAR. Biochim Biophys Acta 2003; 1653: 73-86.
4. Lin Q, Taylor SJ, Shalloway D. Specificity and determinants of Sam68 RNA binding. Implications for the biological function of K homology domains. J Biol Chem 1997; 272: 27274-27280.
5. Matter N, Herrlich P, Konig H. Signal-dependent regulation of splicing via phosphorylation of Sam68. Nature 2002; 420: 691-695.
6. Paronetto MP, Achsel T, Massiello A et al. The RNA-binding protein Sam68 modulates the alternative splicing of Bcl-x. J Cell Biol 2007; 176: 929-939.
7. Chawla G, Lin CH, Han A et al. Sam68 regulates a set of alternatively spliced exons during neurogenesis. Mol Cell Biol 2009; 29: 201-213.
8. Paronetto MP, Cappellari M, Busa R et al. Alternative splicing of the cyclin D1 proto-oncogene is regulated by the RNA-binding protein Sam68. Cancer Res 2010; 70: 229-239.
9. Taylor SJ, Shalloway D. An RNA-binding protein associated with Src through its SH2 and SH3 domains in mitosis. Nature 1994; 368: 867-871.
10. Derry JJ, Richard S, Valderrama Carvajal H et al. Sik (BRK) phosphorylates Sam68 in the nucleus and negatively regulates its RNA binding ability. Mol Cell Biol 2000; 20: 6114-6126.
11. Aubele M, Walch AK, Ludyga N et al. Prognostic value of protein tyrosine kinase 6 (PTK6) for long-term survival of breast cancer patients. Br J Cancer 2008; 99: 1089-1095.
12. Sanchez-Margalet V, Najib S. Sam68 is a docking protein linking GAP and PI3K in insulin receptor signaling. Mol Cell Endocrinol 2001; 183: 113-121.
13. Bedford MT, Frankel A, Yaffe MB et al. Arginine methylation inhibits the binding of proline-rich ligands to Src homology 3, but not WW, domains. J Biol Chem 2000; 275: 16030-16036.
14. Busa R, Paronetto MP, Farini D et al. The RNA-binding protein Sam68 contributes to proliferation and survival of human prostate cancer cells. Oncogene 2007; 26: 4372-4382.
15. Zhang Z, Li J, Zheng H et al. Expression and cytoplasmic localization of SAM68 is a significant and independent prognostic marker for renal cell carcinoma. Cancer Epidemiol Biomarkers Prev 2009; 18: 2685-2693.
16. Song L, Wang L, Li Y et al. Sam68 up-regulation correlates with, and its downregulation inhibits, proliferation and tumourigenicity of breast cancer cells. J Pathol 2010; 222: 227-237.
17. Valacca C, Bonomi S, Buratti E et al. Sam68 regulates EMT through alternative splicing-activated nonsense-mediated mRNA decay of the SF2/ASF protooncogene. J Cell Biol 2010; 191: 87-99.
18. Richard S, Vogel G, Huot ME et al. Sam68 haploinsufficiency delays onset of mammary tumorigenesis and metastasis. Oncogene 2008; 27: 548-556.
19. Hahn WC, Dessain SK, Brooks MW et al. Enumeration of the simian virus 40 early region elements necessary for human cell transformation. Mol Cell Biol 2002; 22: 2111-2123.
20. Soumaoro LT, Uetake H, Higuchi T et al. Cyclooxygenase-2 expression: a significant prognostic indicator for patients with colorectal cancer. Clin Cancer Res 2004; 10: 8465-8471.
21. Benedet JL, Bender H, Jones H 3rd et al. FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO Committee on Gynecologic Oncology. Int J Gynaecol Obstet 2000; 70: 209-262.
22. NCCN. NCCN Clinical Practice Guidelines in Oncology-Cervical Cancer. 2011; V1 http://www.nccn.org/professionals/physician_gls/f_guidelines.asp (17 May 2011, date last accessed).
23. Selman TJ, Mann C, Zamora J et al. Diagnostic accuracy of tests for lymph node status in primary cervical cancer: a systematic review and meta-analysis. CMAJ 2008; 178: 855-862.
24. Altgassen C, Hertel H, Brandstadt A et al. Multicenter validation study of the sentinel lymph node concept in cervical cancer: AGO Study Group. J Clin Oncol 2008; 26: 2943-2951.
25. Juretzka MM, Jensen KC, Longacre TA et al. Detection of pelvic lymph node micrometastasis in stage IA2-IB2 cervical cancer by immunohistochemical analysis. Gynecol Oncol 2004; 93: 107-111.
26. Wangsa D, Heselmeyer-Haddad K, Ried P et al. Fluorescence in situ hybridization markers for prediction of cervical lymph node metastases. Am J Pathol 2009; 175 (6): 2637-2645.
27. Polyak K, Weinberg RA. Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat Rev Cancer 2009; 9: 265-273.
28. Hagemann T, Bozanovic T, Hooper S et al. Molecular profiling of cervical cancer progression. Br J Cancer 2007; 96: 321-328.
29. Hsu YM, Chen YF, Chou CY et al. KCl cotransporter-3 down-regulates Ecadherin/ beta-catenin complex to promote epithelial-mesenchymal transition. Cancer Res 2007; 67: 11064-11073.
30. Lee MY, Chou CY, Tang MJ, Shen MR. Epithelial-mesenchymal transition in cervical cancer: correlation with tumor progression, epidermal growth factor receptor overexpression, and snail up-regulation. Clin Cancer Res 2008; 14: 4743-4750.
31. Lukong KE, Larocque D, Tyner AL, Richard S. Tyrosine phosphorylation of sam68 by breast tumor kinase regulates intranuclear localization and cell cycle progression. J Biol Chem 2005; 280: 38639-38647.
32. Cote J, Boisvert FM, Boulanger MC et al. Sam68 RNA binding protein is an in vivo substrate for protein arginine N-methyltransferase 1. Mol Biol Cell 2003; 14: 274-287.